About DAYBUE®

Maddy, age 21, living with Rett syndrome, with her familyMaddy, age 21, living with Rett syndrome, with her family

Maddy, age 21, on DAYBUE
since 2020, with her family

How was DAYBUE studied?

Caregivers and doctors played a key role in evaluating DAYBUE during the LAVENDER™ study

Doctors evaluated if patients improved or got worse, while caregivers looked for changes in the symptoms of Rett syndrome. See the results from the clinical study below.

Caregivers used the Rett Syndrome Behaviour Questionnaire (RSBQ) to evaluate changes in the signs and symptoms of Rett syndrome.

Doctors used the Clinical Global Impression-Improvement (CGI-I) scale to evaluate if Rett symptoms had improved or worsened.

Study comparison icon
Study design

The effectiveness and safety of DAYBUE were evaluated in the 12-week LAVENDER clinical study of 187 female patients aged 5 to 20 with Rett syndrome

Expand to view 

Study results

Caregivers evaluated changes in a range of symptoms using the RSBQ

RSBQ is a behavior questionnaire completed by caregivers to evaluate the range of symptoms of Rett syndrome.

What does the RSBQ measure?

Irregular breathing patterns icon

Breathing

Unusual hand movements icon

Hand movements or stereotypies

Repetitive behaviors icon

Repetitive behaviors

Nighttime behaviors icon

Nighttime behaviors

Vocalizations icon

Vocalizations

Facial expressions icon

Facial expressions

Eye gaze icon

Eye gaze

Mood icon

Mood

  • Caregivers evaluated 45 items on the RSBQ. Each item was scored as not true (0), somewhat or sometimes true (1), or very true or often true (2)

  • These scores were added together to create the RSBQ total score

  • Researchers looked at the change in average RSBQ total score from the start of the study to measure how DAYBUE impacted the symptoms of Rett at Week 12 when compared to patients receiving placebo

At 12 weeks, caregivers observed:

Figure with heart icon

Significant improvements in the symptoms of Rett syndrome as measured by average change in RSBQ total score with DAYBUE vs placebo

  • At 12 weeks, the group of patients receiving DAYBUE (n=76) saw a decrease of 4.9 in average RSBQ total score from the start of the study when compared with a decrease of 1.7 in the placebo group (n=85), meaning an improvement in Rett symptoms

  • The difference between the 2 groups was -3.2. A lower score meant symptoms of Rett syndrome were less severe

  • Before starting treatment, the average RSBQ total score for the DAYBUE group was 43.7. For the placebo group, the average RSBQ total score before treatment was 44.5

  • Results varied between patients in the clinical study. The effect of DAYBUE on individual symptoms measured by RSBQ has not been shown. Individual results may vary with DAYBUE

What may be possible with DAYBUE?

Caregiver’s description of improvements with DAYBUE:

Symptom
areas
(RSBQ)
Quinn, 5 years oldQuinn, 5 years old
Quinn6 years old Taking DAYBUE
since 2021
Clare, 8 years oldClare, 8 years old
Clare9 years old Taking DAYBUE
since 2021
Kate, 9 years oldKate, 9 years old
Kate9 years old Taking DAYBUE
since 2021
Maddy, 20 years oldMaddy, 20 years old
Maddy21 years old Taking DAYBUE
since 2020
Caitlin, 25 years oldCaitlin, 25 years old
Caitlin25 years old Taking DAYBUE
since 2023
Hand movements or stereotypies
More control of hands. Can hold objects longer. Not grasping her body and face as much Hands are more fluid and open, can hold a fork or cup, taps on fridge when hungry More purposeful hand use. Able to use a spoon and point at and touch her tablet Less aggressive hand movements. A little more control of handsHands have been more relaxed and has more control over them
Repetitive behaviors icon
Repetitive behaviors
Teeth grinding much improvedHardly grinds her teeth anymore
Irregular breathing patterns icon
Breathing
Less frequent breath holding and less hyperventilatingFewer “blue spells” (breath holding)Holds her breath less often. Before DAYBUE, was holding her breath on and off throughout the day
Nighttime behaviors icon
Nighttime behaviors
Less frequent night terrors allow her to sleep better Fewer night terrors and laughing spells - now family gets more sleep
Vocalizations icon
Vocalizations
Increased nonverbal vocalizations, able to let people know when she wants something No words, but makes more sounds to respondMore purposeful
Facial expressions icon
Facial
expressions
Doesn't stick her tongue out as oftenIncrease in facial expressions. She looks at people when they are talking to her and smiles more
Eye gaze icon
Eye gaze
Can hold her gaze to participate and engage, especially in the classroom Uses eye gaze more to convey feelings, needs, and wishes. Allows her to show family what she wants for a snack Able to use her eye-gaze device better to convey wishes Makes choices more quickly with her eyes. More of an interest in using her eye-gaze device Makes eye contact consistently; indicates she is listening to people by looking at them
Mood icon
Mood
Her moods are more predictable and cries a lot less Less screaming and tantrums. Able to take an interest in the things around her More peaceful at home, in school, and in groups Mood is better, happier, much less crying for no apparent reason Appears happier and has been laughing more with us
Clare, age 9, living with Rett syndrome, with her momClare, age 9, living with Rett syndrome, with her mom

Learn from caregivers and their individual loved one’s experience with DAYBUE

View DAYBUE stories

Clare, age 9, on DAYBUE since 2021, with her mom

At 12 weeks, doctors observed:

Doctor-icon

Significant improvements in the signs and symptoms of Rett syndrome as measured by the CGI-I scale vs placebo

The CGI-I scale was used by doctors to evaluate improvement or worsening of Rett symptoms

  • 38% of patients (n=77) had improvements in symptoms with DAYBUE vs 15% of patients (n=86) taking placebo

    • Much improved (13% vs 5% for placebo), minimally improved (25% vs 10%)

  • 61% of patients had no improvements in symptoms with DAYBUE vs 81% of patients taking placebo. Individual results may vary

Lara, Acadia Family Support EducatorLara, Acadia Family Support Educator

Lara, Family Support Educator

Do you have questions about treatment with DAYBUE?


While treatment with DAYBUE is a decision you and your loved one's doctor can make, Family Support Educators can help answer your questions about Rett syndrome, comprehensive care, and connecting with other caregivers.

Get connected with a Family Support Educator

Lara, Family Support Educator

Understanding the possible side effects of DAYBUE or DAYBUE STIX

As with any medication, it’s important to talk to your loved one's doctor about the possibility of side effects with DAYBUE or DAYBUE STIX. Not every person will experience the same side effects, and for some people, certain side effects, such as diarrhea and vomiting, may be more severe than others.

Side effects may include:

Diarrhea icon

Diarrhea:

Diarrhea is a common side effect of DAYBUE or DAYBUE STIX that can sometimes be severe. Diarrhea may cause your loved one to lose too much water from their body (dehydration). Before starting treatment with DAYBUE or DAYBUE STIX, stop taking laxatives. Tell your doctor if your loved one has diarrhea while taking DAYBUE or DAYBUE STIX. Your doctor may ask you to increase the amount your loved one drinks or give antidiarrheal medicine as needed.

upset stomach icon

Vomiting:

Vomiting is a common side effect of DAYBUE or DAYBUE STIX. Sometimes vomit can get into your loved one's lungs (aspiration), which could cause an infection (aspiration pneumonia). Tell your doctor if your loved one has severe vomiting or if vomiting happens often.

Scale icon

Weight loss:

DAYBUE or DAYBUE STIX can cause weight loss. Tell your doctor if you notice your loved one is losing weight at any time during treatment with DAYBUE or DAYBUE STIX.

Common side effects in the 12-week LAVENDER trialCommon side effects in the 12-week LAVENDER trial

Learn how to help manage possible side effects

Management guidance

Is DAYBUE right for your child?

The DAYBUE Overview Brochure provides information about  treatment with DAYBUE.

The DAYBUE® Overview Brochure provides information about DAYBUE clinical study results, safety facts, caregiver experiences, and helpful treatment tips.

Download Overview Brochure
The DAYBUE Treatment Discussion Guide can help you prepare for a conversation with your loved one's doctor.

The DAYBUE Treatment Discussion Guide is a tool you can use to talk to your loved one's doctor about DAYBUE.

Download Treatment Discussion Guide

Support by your side

Acadia Connect® is a patient and family support program that connects you and your family with educational support and resources throughout the DAYBUE treatment journey.

Call Acadia Connect at 1-844-737-2223, Monday to Friday, 8am to 8pm ET, to learn more about our individualized support program designed to help meet the needs of your loved one taking DAYBUE.

Learn how we can help
Joe, Acadia Family Support Educator making heart with hands.Joe, Acadia Family Support Educator making heart with hands.
Daybue (trofinetide) oral solutionDaybue Stix (trofinetide) for oral solution